Clinical Mass spectrometry proteomics (cMSP) for medical laboratory: What does the future hold?

Lehmann, Sylvain; Brede, Cato; Lescuyer, Pierre; Cocho, José A.; Vialaret, Jérôme; Bros, Pauline; Delatour, Vincent; Hirtz, Christophe

doi:10.1016/j.cca.2016.06.001

Scientific article

English

Clinical Mass spectrometry proteomics (cMSP) for medical laboratory: What does the future hold?

ContributorsLehmann, Sylvain; Brede, Cato; Lescuyer, Pierre

; Cocho, José A.; Vialaret, Jérôme; Bros, Pauline; Delatour, Vincent; Hirtz, Christophe

Published inClinica chimica acta, vol. 467, p. 51-58

Publication date2017

Abstract

BACKGROUND: Mass spectrometry (MS) methods are being widely used these days in medical laboratories for quantifying many small molecular analytes as well as for microbiological purposes.

Keywords

Proteomics
Mass spectrometry
Laboratory medicine
Clinical chemistry

Affiliation entities

Faculté de médecine / Section de médecine fondamentale / Département de biologie structurale et bioinformatique

Research groups

Auto-immunité, inflammation et athérosclérose (270)

Citation (ISO format)

LEHMANN, Sylvain et al. Clinical Mass spectrometry proteomics (cMSP) for medical laboratory: What does the future hold? In: Clinica chimica acta, 2017, vol. 467, p. 51–58. doi: 10.1016/j.cca.2016.06.001

Article (Accepted version)

Identifiers

PID : unige:84649
DOI : 10.1016/j.cca.2016.06.001

Additional URL for this publicationhttp://www.elsevier.com/locate/issn/00098981

Journal ISSN0009-8981

654views

2downloads

Creation07/06/2016 11:23:00

First validation07/06/2016 11:23:00

Update23/01/2025 11:33:18

Status update23/01/2025 11:33:18

Last indexation23/01/2025 11:41:11

Archive ouverte UNIGE

Clinical Mass spectrometry proteomics (cMSP) for medical laboratory: What does the future hold?

BACKGROUND: Mass spectrometry (MS) methods are being widely used these days in medical laboratories for quantifying many small molecular analytes as well as for microbiological purposes.

Technical informations